CCR6 as a possible therapeutic target in psoriasis

Importance of the field: Psoriasis is a common, chronic autoimmune disease of the skin. Despite a number of effective treatments, new therapies are needed with enhanced efficacy, safety and convenience. Chemokine receptors are GPCRs that control leukocyte trafficking, and like other GPCRs, are good...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hedrick, Michael N. (VerfasserIn) , Lonsdorf, Anke Susanne (VerfasserIn) , Hwang, Sam T. (VerfasserIn) , Farber, Joshua M. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 July 2010
In: Expert opinion on therapeutic targets
Year: 2010, Jahrgang: 14, Heft: 9, Pages: 911-922
ISSN:1744-7631
DOI:10.1517/14728222.2010.504716
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1517/14728222.2010.504716
Volltext
Verfasserangaben:Michael N. Hedrick, Anke S. Lonsdorf, Sam T. Hwang, Joshua M. Farber

MARC

LEADER 00000caa a2200000 c 4500
001 1841953776
003 DE-627
005 20230710144107.0
007 cr uuu---uuuuu
008 230411s2010 xx |||||o 00| ||eng c
024 7 |a 10.1517/14728222.2010.504716  |2 doi 
035 |a (DE-627)1841953776 
035 |a (DE-599)KXP1841953776 
035 |a (OCoLC)1389806869 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hedrick, Michael N.  |e VerfasserIn  |0 (DE-588)128590267X  |0 (DE-627)1841954756  |4 aut 
245 1 0 |a CCR6 as a possible therapeutic target in psoriasis  |c Michael N. Hedrick, Anke S. Lonsdorf, Sam T. Hwang, Joshua M. Farber 
264 1 |c 15 July 2010 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.04.2023 
520 |a Importance of the field: Psoriasis is a common, chronic autoimmune disease of the skin. Despite a number of effective treatments, new therapies are needed with enhanced efficacy, safety and convenience. Chemokine receptors are GPCRs that control leukocyte trafficking, and like other GPCRs, are good potential drug targets. The chemokine receptor CCR6 is expressed on the TH17 subset of CD4+ T cells, which produces IL-17A/F, IL-22, TNF-α and other cytokines, and which has been implicated in the pathogenesis of psoriasis. CCR6 and its ligand, CCL20/MIP-3α, are highly expressed in psoriatic skin and CCR6 is necessary for the pathology induced in a mouse model of psoriasis-like inflammation.Areas covered in this review: This review summarizes the evidence for the importance of the IL-23/TH17 axis, and in particular CCR6 and CCL20 in psoriasis, dating from 2000 to the present, and discusses the possibility of inhibiting CCR6 as a treatment for the disease.What the reader will gain: The review informs the reader of the current thinking on the mechanisms of inflammation in psoriasis and the possible roles for CCR6 (and CCL20) in disease pathogenesis.Take home message: We conclude that CCR6 should be investigated as a potential therapeutic target in psoriasis. 
650 4 |a autoimmune disease 
650 4 |a chemokines 
650 4 |a inflammation 
650 4 |a psoriasis 
700 1 |a Lonsdorf, Anke Susanne  |d 1977-  |e VerfasserIn  |0 (DE-588)130004944  |0 (DE-627)486918939  |0 (DE-576)297945904  |4 aut 
700 1 |a Hwang, Sam T.  |e VerfasserIn  |4 aut 
700 1 |a Farber, Joshua M.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Expert opinion on therapeutic targets  |d Abingdon, Oxon : Routledge, Taylor & Francis, 2001  |g 14(2010), 9 vom: Juli, Seite 911-922  |h Online-Ressource  |w (DE-627)324531923  |w (DE-600)2028202-3  |w (DE-576)301538425  |x 1744-7631  |7 nnas  |a CCR6 as a possible therapeutic target in psoriasis 
773 1 8 |g volume:14  |g year:2010  |g number:9  |g month:07  |g pages:911-922  |g extent:13  |a CCR6 as a possible therapeutic target in psoriasis 
856 4 0 |u https://doi.org/10.1517/14728222.2010.504716  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230411 
993 |a Article 
994 |a 2010 
998 |g 130004944  |a Lonsdorf, Anke Susanne  |m 130004944:Lonsdorf, Anke Susanne  |d 910000  |d 911300  |e 910000PL130004944  |e 911300PL130004944  |k 0/910000/  |k 1/910000/911300/  |p 2 
999 |a KXP-PPN1841953776  |e 4307312678 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"15 July 2010","dateIssuedKey":"2010"}],"note":["Gesehen am 11.04.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"CCR6 as a possible therapeutic target in psoriasis","title":"CCR6 as a possible therapeutic target in psoriasis"}],"recId":"1841953776","language":["eng"],"name":{"displayForm":["Michael N. Hedrick, Anke S. Lonsdorf, Sam T. Hwang, Joshua M. Farber"]},"physDesc":[{"extent":"13 S."}],"relHost":[{"id":{"eki":["324531923"],"zdb":["2028202-3"],"issn":["1744-7631"]},"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"14","text":"14(2010), 9 vom: Juli, Seite 911-922","year":"2010","pages":"911-922","issue":"9","extent":"13"},"disp":"CCR6 as a possible therapeutic target in psoriasisExpert opinion on therapeutic targets","title":[{"title":"Expert opinion on therapeutic targets","title_sort":"Expert opinion on therapeutic targets"}],"pubHistory":["Volume 5, issue 3 (2001)-"],"titleAlt":[{"title":"ETT"}],"language":["eng"],"recId":"324531923","note":["Gesehen am 07.11.24"],"origin":[{"publisherPlace":"Abingdon, Oxon ; London [u.a.]","dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisher":"Routledge, Taylor & Francis ; Informa Healthcare"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Michael N.","family":"Hedrick","display":"Hedrick, Michael N."},{"family":"Lonsdorf","given":"Anke Susanne","role":"aut","roleDisplay":"VerfasserIn","display":"Lonsdorf, Anke Susanne"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Hwang","given":"Sam T.","display":"Hwang, Sam T."},{"display":"Farber, Joshua M.","given":"Joshua M.","family":"Farber","role":"aut","roleDisplay":"VerfasserIn"}],"id":{"eki":["1841953776"],"doi":["10.1517/14728222.2010.504716"]}} 
SRT |a HEDRICKMICCCR6ASAPOS1520